Fecal calprotectin concentration to assess endoscopic and histologic remission in patients with cancer with immune-mediated diarrhea and colitis.

Fangwen ZouXuemei WangIsabella C Glitza OlivaJennifer L McQuadeJennifer WangHao Chi ZhangJohn A ThompsonAnusha S ThomasYinghong Wang

Published in: Journal for immunotherapy of cancer (2021)

FC concentration may serve as a non-invasive biomarker to predict endoscopic and histologic remission in patients receiving treatment for IMDC, minimizing the need for frequent invasive endoscopies. Future prospective studies are needed to provide further insight on the role of this marker in disease surveillance.

Keyphrases

disease activity
ultrasound guided
ulcerative colitis
public health
rheumatoid arthritis
systemic lupus erythematosus
current status
case control
combination therapy